Status:
UNKNOWN
Culture System for Isolating Circulating Tumor cells_2
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Early Diagnosis
Diagnostic Techniques and Procedures
Eligibility:
All Genders
20-70 years
Brief Summary
This culture system utilizes the special affinity difference of biomedical material coating for different cells to achieve the effect of isolating tumor cells from the blood sample. The coating of the...
Eligibility Criteria
Inclusion
- Patients with lung cancer are between the ages of 20 and 70
- Willing to sign the consent form under the informed consent
Exclusion
- Vulnerable Subjects included minors, prisoners, aborigines, pregnant women, people with mental disorders, students, and subordinates, etc.
Key Trial Info
Start Date :
October 31 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2020
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT04125667
Start Date
October 31 2019
End Date
August 31 2020
Last Update
October 14 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan